TTM
$1.03B
YoY change
+52.0%
5Y CAGR
+24.9%
Peak year (2025)
$911.80M
Cumulative operating income
$2.65B
Operating Income history chart for DexCom (DXCM) from 2000 to 2025
Latest: $911.80M
Operating Income growth chart for DexCom (DXCM) from 2000 to 2025
Latest: +52.0%
Operating Income history table for DexCom (DXCM) from 2000 to 2025
| 2025 | $911.80M | +52.0% | +$311.80M | ||
| 2024 | $600.00M | +0.4% | +$2.30M | ||
| 2023 | $597.70M | +52.8% | +$206.50M | ||
| 2022 | $391.20M | +47.2% | +$125.40M | ||
| 2021 | $265.80M | -11.3% | −$33.70M | ||
| 2020 | $299.50M | +110.5% | +$157.20M | ||
| 2019 | $142.30M | -176.4% | +$328.60M | ||
| 2018 | −$186.30M | +338.4% | −$143.80M | ||
| 2017 | −$42.50M | -33.5% | +$21.40M | ||
| 2016 | −$63.90M | +11.9% | −$6.80M | ||
| 2015 | −$57.10M | +165.6% | −$35.60M | ||
| 2014 | −$21.50M | -25.6% | +$7.40M | ||
| 2013 | −$28.90M | -48.1% | +$26.80M | ||
| 2012 | −$55.70M | +24.2% | −$10.86M | ||
| 2011 | −$44.84M | -1.0% | +$447.00K | ||
| 2010 | −$45.29M | -1.2% | +$543.00K | ||
| 2009 | −$45.83M | -13.2% | +$6.99M | ||
| 2008 | −$52.83M | +13.2% | −$6.15M | ||
| 2007 | −$46.68M | -5.4% | +$2.64M | ||
| 2006 | −$49.32M | +52.1% | −$16.89M | ||
| 2005 | −$32.43M | +130.5% | −$18.36M | ||
| 2004 | −$14.07M | +38.1% | −$3.88M | ||
| 2003 | −$10.18M | +61.4% | −$3.87M | ||
| 2002 | −$6.31M | -6.1% | +$413.09K | ||
| 2001 | −$6.72M | +67.5% | −$2.71M | ||
| 2000 | −$4.01M | — | — |
- 2025$911.80M+52.0%
- 2024$600.00M+0.4%
- 2023$597.70M+52.8%
- 2022$391.20M+47.2%
- 2021$265.80M-11.3%
- 2020$299.50M+110.5%
- 2019$142.30M-176.4%
- 2018−$186.30M+338.4%
- 2017−$42.50M-33.5%
- 2016−$63.90M+11.9%
- 2015−$57.10M+165.6%
- 2014−$21.50M-25.6%
- 2013−$28.90M-48.1%
- 2012−$55.70M+24.2%
- 2011−$44.84M-1.0%
- 2010−$45.29M-1.2%
- 2009−$45.83M-13.2%
- 2008−$52.83M+13.2%
- 2007−$46.68M-5.4%
- 2006−$49.32M+52.1%
- 2005−$32.43M+130.5%
- 2004−$14.07M+38.1%
- 2003−$10.18M+61.4%
- 2002−$6.31M-6.1%
- 2001−$6.72M+67.5%
- 2000−$4.01M—
Operating Income values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current operating income (TTM) is $1.03B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DexCom (DXCM) most recent annual operating income stands at $911.80M (2025) – surged 52.0% year-over-year.
DexCom operating income has grown for 4 consecutive years, with a +24.9% compound annual growth rate over 2020–2025 (5 years).
The record annual operating income stands at $911.80M, reached in 2025; the historical low of −$186.30M was recorded in 2018.
DexCom Operating Income by Year
DexCom Operating Income 2025: $911.80M
DexCom operating income in 2025 was $911.80M, surged 52.0% from 2024. This figure represents the highest annual value in the available history.
DexCom Operating Income 2024: $600.00M
2024's operating income for DexCom came in at $600.00M, edged up 0.4% from 2023.
DexCom Operating Income 2023: $597.70M
DexCom posted operating income of $597.70M in 2023, surged 52.8% from 2022.
DexCom Operating Income 2022: $391.20M
In 2022, DexCom reported operating income of $391.20M, surged 47.2% from 2021.
DexCom Operating Income 2021: $265.80M
DexCom operating income in 2021 was $265.80M.
See more financial history for DexCom (DXCM).
Sector peers by Operating Income
Healthcare peers of DexCom (DXCM), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation